5mg BPC-157, 2mg TB4, 1mg MGF, and 2mg KPV in a 3mL sterile glass vial
Introduction
This formulation combines four distinct peptides that have garnered significant interest in various research applications. The combination includes BPC-157, TB4 (Thymosin Beta-4), MGF (Mechano Growth Factor), and KPV, each representing different structural categories and research focuses within peptide science.
Scientific Background
These peptides have emerged from different areas of biological research. BPC-157 is a synthetic peptide derived from a protein found in gastric juice, first isolated and studied in the 1990s. TB4 is a naturally occurring peptide identified in thymic tissue. MGF represents a splice variant of IGF-1 that has been studied in muscle biology research. KPV is a tripeptide fragment derived from alpha-melanocyte stimulating hormone, studied for its interaction with various cellular pathways.
Structural Information
- BPC-157: 15-amino acid synthetic peptide (5mg)
- TB4: 43-amino acid peptide (2mg)
- MGF: Modified growth factor peptide variant (1mg)
- KPV: Tripeptide sequence (Lysine-Proline-Valine) (2mg)
- Formulation: Combined in 3mL sterile glass vial
Disclaimer:
This information is provided for educational and research purposes only. GLP-1 and GIP combined is a research compound not approved for human use. These statements have not been evaluated by the FDA or any regulatory authority. This compound is not intended to diagnose, treat, cure, or prevent any disease or medical condition.
Research use of this compound should only be conducted by qualified professionals in appropriate laboratory settings with proper institutional oversight and in compliance with all applicable regulations. Not for human consumption or clinical use.
The information presented reflects current scientific literature available for educational review and does not constitute medical advice or therapeutic recommendations.